- Published at
- by gurufocus.com
neutral
neutral
BioVie (BIVI) Launches Phase 2 SUNRISE-PD Trial for Parkinson's Treatment | BIVI Stock News
BioVie Inc. (BIVI) has commenced patient enrollment for its Phase 2 SUNRISE-PD clinical trial. This study aims to assess the safety and efficacy of bezisterim i